NetworkNewsWire Announces Publication on Investment Opportunities in Canada's Cannabis Market

NEW YORK, NY--(Marketwired - Sep 22, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis.

The publication, titled, "Production Bottleneck Spells Opportunity for Canada's Cannabis Producers," highlights the licensed producers that are expanding to keep up with the demand for medical marijuana in Canada.

To view the full publication, visit: https://www.networknewswire.com/production-bottleneck-spells-opportunity-canadas-cannabis-producers/

"Data from Health Canada suggest that almost 130,000 Canadians had signed up with the country's 38 licensed cannabis producers by the end of 2016, more than tripling in number from the previous year. One of these licensed producers is ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN) (ABCCF Profile), which has remained focused on changing the face of medical cannabis since its launch in 2014.

"Leaning on this reputation for quality, ABcann has already outlined some aggressive expansion plans designed to help it widen its presence in the fertile Canadian cannabis market. The company's Vanluven facility in Napanee, Ontario, boasts 15,000 square feet of production space, and management expects completion of an additional 15,000-square-foot expansion at the site sometime in 2017. Looking ahead, ABcann also owns a 2,649-hectare parcel of land near its Vanluven facility, known as its Kimmett facility, upon which it plans to construct a 150,000-square-foot facility offering annual cannabis production capacity of 20,000 kilograms."

About ABcann Global Corporation

ABcann was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann's flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann's modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product.